OBSTETRIC MANAGEMENT IN PREGNANT WOMEN WITH HEART DISEASE: A REVIEW OF THREE YEARS (2018-2020)

Thị Huyền Hoàng1,, Mạnh Thắng Nguyễn2,3
1 Quoc oai general hospital
2 Hanoi medical university
3 National hospital of obstetrics and gynecology

Main Article Content

Abstract

The objective of the study was to describe the obstetric management and pregnancy outcomes of pregnant women with heart disease for 3 years (2018-2020) at the National Hospital of Obstetrics and Gynecology (NHOG). The research method is descriptive retrospective. Research results show that in 3 years, 331 women with heart disease with gestational age of 22 weeks or more ended their pregnancy at NHOG. Full term pregnancy accounted for the majority with 91.8%. C-section was the main method of ending pregnancy (88.2%), and normal delivery accounts for 11.8%. Indications for C-section was mainly on the obstetric (43%). C-section alone accounted for 70%, C-section with sterilization accounted for 30%. The most common cardiovascular complication was heart failure (65%), arrhythmia ranked second at 18%, no maternal mortality. In the group of fetuses with adverse outcomes, premature delivery accounted for the highest rate of 8.6%, intrauterine growth retardation accounted for 6.2%, and mortality newborns accounted for 2.6%.

Article Details

References

1. Phan Trường Duyệt. Bệnh tim và thai nghén. Lâm sàng Sản Phụ Khoa. NXB Y học; 1999:199-205.
2. Endorsed by the European Society of Gynecology (ESG) the A for EPC (AEPC) and the German Society for Gender Medicine (DGesGM), Authors/Task Force Members, Regitz-Zagrosek V, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147-3197. doi:10.1093/eurheartj/ehr218
3. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(34):3165-3241. doi:10.1093/ eurheartj/ehy340
4. Nguyễn Bảo Giang. Nhận xét về tình hình và kết quả điều trị bệnh tim và thai nghén tại Bệnh viện Phụ sản trung ương (từ tháng 1/2000 đến 9/2004). Luận văn Thạc sỹ Y học, Trường Đại học Y Hà Nội; 2004.
5. Lê Thị Huyền. Nghiên cứu xử trí sản khoa với sản phụ bị bệnh tim từ 22 tuần trở lên tại Bệnh viện Phụ Sản Trung Ương. Luận văn Thạc sĩ y học. Trường Đại học Y Hà Nội; 2018.
6. Gohlke-Bärwolf C. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism]. Z Kardiol. 2001;90 Suppl 4:49-56.
7. Anticoagulation During Pregnancy. Published online December 30, 2021. Accessed September 25, 2022. https:// ashpublications.org/ ashclinicalnews/news/3532/Anticoagulation-During-Pregnancy
8. ESC Guidelines on Infective Endocarditis (Prevention, Diagnosis and Treatment of).